Hepatic toxicity and recovery of fischer 344 rats following exposure to 2-aminoanthracene by intraperitoneal injection

Toxicologic Pathology

Volumn 29, Issue 3, 2001, Pages 328-332

  Baker, David G ^a   Taylor, H Wayne ^a   Lee, Stephen P ^a   Barker, Steven A ^a   Goad, Mary E P ^a,c   Means, Jay C ^c  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b WESTERN MICHIGAN UNIVERSITY   (United States)

^c NONE

Author keywords

Animal model; arylamine; liver; polycyclic aromatic hydrocarbon (PAH)

Indexed keywords

2 AMINOANTHRACENE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; GLOBULIN; POLYCYCLIC AROMATIC HYDROCARBON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; LIVER ADENOMA; LIVER HYPERTROPHY; LIVER TOXICITY; MALE; NODULAR HYPERPLASIA; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; WEIGHT GAIN;

ADENOMA; ALBUMINS; ALKALINE PHOSPHATASE; ANIMALS; ANTHRACENES; ASPARTATE AMINOTRANSFERASES; BLOOD PROTEINS; BODY WEIGHT; CARCINOGENS; DISEASE-FREE SURVIVAL; FOCAL NODULAR HYPERPLASIA; GLOBULINS; INJECTIONS, INTRAPERITONEAL; LIVER; LIVER NEOPLASMS; MALE; MUTAGENS; RATS; RATS, INBRED F344; REMISSION INDUCTION; WEIGHT GAIN;

ANIMALIA;

EID: 0034959856     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1080/019262301316905282     Document Type: Article

References (26)

1. Beland FA, Kadlubar FF (1985). Formation and persistence of arylamine DNA adducts in vivo. Environ Health Perspect 62: 19-30.
2. Bitsch A., Klohn PC, Hadjiolov N., Bergmann O., Neumann HG (1999). New insights into carcinogenesi s of the classical model arylamine 2-acetylaminofluorene. Cancer Lett 143: 223-227.
3. Boudreau MD, Baker DG, Taylor HW, Barker SA, Means JC (2000). Suppression of Arylamine Activation in the Fischer-344 Rat Following Ingestion of a Complex Mixture. Toxicol Pathol. Submitted for publication.
4. Bruckner JV, MacKenzie WF, Muralidhara S., Luthra R., Kyle GM, Acosta D. (1986). Oral toxicity of carbon tetrachloride: Acute, subacute, and sub-chronic studies in rats. Fundam Appl Toxicol 6: 16-34.
5. Dabeva MD, Alpini G, Hurston E, Shafritz DA (1993). Models for hepatic progenitor cell activation. Proc Soc Exp Biol Med 204: 242-252.
6. Davis DP, Gomez MP, Barton SL, Montano RM, Burchiel SW (1991). Suppression of local gut-associated and splenic mitogen responsiveness of lymphoid cells following oral exposure of B6C3F1 mice to 7,12-dimethylbenz(a)anthracene. Fundam Appl Toxicol 17: 429-431.
7. Feng Y., Fretland AJ, Rustan TD, Jiang W., Becker WK, Hein DW (1997). Higher frequency of aberrant crypt foci in rapid than slow acetylator inbred rats administered the colon carcinogen 3,2’-dimethyl-4-aminobiphenyl. Toxicol Appl Pharmacol 147: 56-62.
8. Green MD, Tephly TR (1998). Glucuronidation of amine substrates by purifi ed and expressed UDP-glucuronosyltransferas e proteins. Drug Metab Dispo 26: 860-867.
9. Hlavica P., Golly I., Lehnerer M., Schulze J. (1997). Primary aromatic amines: Their N-oxidative bioactivation. Hum Exp Toxicol 16: 441-448.
10. King RS, Teitel CH, Shaddock JG, Casciano DA, Kadlubar FF (1999). Detoxifi cation of carcinogenic aromatic and heterocyclic amines by enzymatic reduction of the N-hydroxy derivative. Cancer Lett 143: 167-171.
11. Kranendonk M., Mesquita P., Laires A., Vermeulen NP, Rueff J. (1998). Expression of human cytochrome P450 1A2 in Escherichia coli: A system for biotransformation and genotoxicity studies of chemical carcinogens. Mutagenesis 13: 263-269.
12. Moghaddam AP, Eggers JS, Calabrese EJ (1998). Evaluation of sex differences in tissue repair following acute carbon tetrachloride toxicity in male and female Sprague—Dawley rats. Toxicol 130: 95-105.
13. Neuman HG, Ambs S., Bitsch A. (1994). The role of nongenotoxic mechanisms in arylamine carcinogenesis. Environ Health Perspect 102: 173-176.
14. Ozawa S., Abu-Zeid M., Murayama N., Yamazoe Y., Kato R. (1990). Decrease in the metabolic activating capacities of arylamines in livers bearing hyperplastic nodules: Association with the selective changes in hepatic P-450 isozymes. Jpn J Cancer Res 81: 247-252.
15. Pinto JS, Dobson RL, Bentley JP (1970). Dermal collagen changes during 2-aminoanthracene carcinogenesi s in the rat. Cancer Res 30: 1168-1173.
16. Rainov NG, Dobberstein KU, Sena-Esteves M., Herrlinger U., Kramm CM, Philpot RM, Hilton J., Chiocca EA, Breakefi eld XO (1998). New prodrug activation gene therapy for cancer using cytochrome P450 4B1 and 2-aminoanthracene/4-ipomeanol. Hum Gene Ther 9: 1261-1273.
17. Rao PS, Mangipudy RS, Mehendale HM (1997). Tissue injury and repair as parallel and opposing responses to CCl4 hepatotoxicity: A novel dose-response. Toxicol 118: 181-193.
18. Roberts-Thomson IC, Butler WJ, Ryan P (1999). Meat, metabolic genotypes and risk for colorectal cancer. Eur J Cancer Prev 8: 207-211.
19. Skipper PL, Tannenbaum SR (1994). Molecular dosimetry of aromatic amines in human populations. Environ Health Perspect 102(suppl 6) 17-21.
20. Soni MG, Mangipudy RS, Mumtaz MM, Mehendale HM (1998). Tissue repair response as a function of dose during trichloroethylen ehepatotoxicity. Toxicol Sci 42: 158-165.
21. Terada M., Nagao M., Nakayasu M., Sakamoto H., Nakasato F., Sugimura T. (1986). Mutagenic activities of heterocyclic amines in Chinese hamsters lung cells in culture. Environ Health Perspect 67: 117-119.
22. Vineis P. (1994). Epidemiology of cancer from exposure to arylamines. Environ Health Perspect 102(suppl 6) 7-10.
23. Vineis P., Pirastu R. (1997). Aromatic amines and cancer. Cancer Causes Control 8: 346-355.
24. Wang P-Y., Kaneko T., Tsukada H., Nakano M., Nakajima T., Sato A. (1997). Time courses of hepatic injuries induced by chloroform and by carbon tetrachloride: Comparison of biochemical and histopathological changes. Arch Toxicol 71: 638-645.
25. Windmill KF, McKinnon RA, Zhu X., Gaedigk A., Grant DM, McManus ME (1997). The role of xenobiotic metabolizing enzymes in arylamine toxicity and carcinogenesis: Functional and localization studies. Mutat Res 376: 153-160.
26. Wise RW, Zenser TV, Kadlubar FF, Davis BB (1984). Metabolic activation of carcinogenic aromatic amines by dog bladder and kidney prostaglandin H synthase. Cancer Res 44: 1893-1897.